Brand Name:- Libtayo
Generic Name:- Cemiplimab-rwlc
Manufacturer:- Sanofi
Dosage:- Injection
Strength:- 350mg/7ml (50mg/ml)
Composition:- Cemiplimab-rwlc
Packaging:- 1vial
Indication:- Skin Cancer
Storage:- Store at room temperature
Overview
Libtayo (Cemiplimab-rwlc) is used to treat a type of skin cancer that has spread to other areas of the body that cannot be treated with radiation or surgery. It is given as an infusion into the vein. Do not self-administer this medicine. Take this medicine as prescribed by your medical advisor. Your doctor will decide the exact dosage. Do not take this medicine in the wrong way as it may lead to some severe side effects. It is advisable not to change or stop the dose without taking suggestions from your doctor. If you experience any symptoms while receiving this medicine, inform your doctor immediately.
Pharmacodynamics Of Libtayo
Cemiplimab inhibits tumor growth by an immune-mediated mechanism, specifically by the inhibition of the programmed death receptor 1 (PD-1) treating cutaneous squamous cell carcinoma. 350mg IV over 30 minutes every 3 weeks until disease progression.


